IP Library Granted Patent US 8,394,621
Granted Patent B2
US 8,394,621 · App. 12/605,204 · Granted Mar 12, 2013

Modified photosynthetic microorganisms for producing triglycerides

Inventors: James Roberts (Seattle, WA); Fred Cross (Seattle, WA); Paul Warrener (Seattle, WA); Ernesto Javier Munoz (Seattle, WA); Martin Henry Lee (Seattle, WA); Khadidja Romari (Seattle, WA); Kimberly Marie Kotovic (Seattle, WA); Jason W. Hickman (Seattle, WA)
Assignee: Matrix Genetrics, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,394,621
App. No.
12/605,204
Granted
Mar 12, 2013
Kind
B2
Abstract

This disclosure describes genetically modified photosynthetic microorganisms, including Cyanobacteria, that contain one or more exogenous genes encoding a diacylglycerol acyltransferase, a phosphatidate phosphatase, and/or an acetyl-CoA carboxylase, and which are capable of producing increased amounts of fatty acids and/or synthesizing triglycerides.

Claims (20)

1. A modified Cyanobacterium comprising an exogenous polynucleotide encoding a prokaryotic diacylglycerol acyltransferase (DGAT), wherein said modified Cyanobacterium produces a triglyceride, a wax ester or both.

2. The modified Cyanobacterium of claim 1 , wherein said DGAT is an Acinetobacter DGAT, a Streptomyces DGAT, or an Alcanivorax DGAT.

3. The modified Cyanobacterium of claim 2 , wherein said DGAT is an Acinetobacter DGAT.

4. The modified Cyanobacterium of claim 3 , wherein said Acinetobacter DGAT is a Acinetobacter baylii ADP1 diacylglycerol acyltransferase (AtfA), or a biologically active fragment or variant thereof.

5. The modified Cyanobacterium of claim 4 , wherein said AtfA comprises a polypeptide sequence set forth in SEQ ID NO:1 or SEQ ID NO:18.

6. The modified Cyanobacterium of claim 2 , wherein said DGAT is a Streptomyces DGAT.

7. The modified Cyanobacterium of claim 6 , wherein said Streptomyces DGAT is a Streptomyces coelicolor DGAT, or a biologically active fragment or variant thereof.

8. The modified Cyanobacterium of claim 7 , wherein said Streptomyces coelicolor DGAT comprises a polypeptide sequence set forth in SEQ ID NO:14.

9. The modified Cyanobacterium of claim 2 , wherein said DGAT is an Alcanivorax DGAT.

10. The modified Cyanobacterium of claim 9 , wherein said Alcanivorax DGAT is an Alcanivorax borkumensis DGAT, or a biologically active fragment or variant thereof.

11. The modified Cyanobacterium of claim 10 , wherein said Alcanivorax borkumensis DGAT comprises a polypeptide sequence set forth in SEQ ID NO:15.

12. The modified Cyanobacterium of claim 1 , wherein said exogenous polynucleotide is present in an expression construct.

13. The modified Cyanobacterium of claim 12 , wherein said expression construct comprises a constitutive promoter.

14. The modified Cyanobacterium of claim 12 , wherein expression construct comprises an inducible promoter.

15. The modified Cyanobacterium of claim 1 , wherein said polynucleotide is codon-optimized for expression in a Cyanobacterium.

16. The modified Cyanobacterium of claim 1 , wherein said Cyanobacterium is selected from the group consisting of: S. elongatus PCC 7942, a salt tolerant variant of S. elongatus PCC 7942 , Synechococcus PCC 7002, and Synechocystis PCC 6803.

17. The modified Cyanobacterium of claim 16 , wherein said Cyanobacterium is a salt tolerant variant of S. elongatus PCC 7942.

18. The modified Cyanobacterium of claim 16 , wherein said Cyanobacterium is Synechocystis PCC 6803.

19. The modified Cyanobacterium of claim 1 , wherein said DGAT is a Acinetobacter baylii ADP1 diacylglycerol acyltransferase (AtfA), or a biologically active fragment or variant thereof, wherein said polynucleotide is codon-optimized for expression in Cyanobacteria, wherein expression of said DGAT is regulated by one or more inducible promoters, and wherein said Cyanobacterium is S. elongatus PCC7942 or a salt tolerant variant thereof.

20. A modified Cyanobacterium comprising an exogenous polynucleotide encoding a prokaryotic diacylglycerol acyltransferase (DGAT) that uses acyl-ACP as a substrate, wherein said modified Cyanobacterium produces a triglyceride, a wax ester or both.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 1, 2023
From: KOTOVIC, KIMBERLY MARIE; HICKMAN, JASON W.
To: TARGETED GROWTH, INC.
Reel/Frame 063834/0559 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2018
From: MATRIX GENETICS, LLC
To: LUMEN BIOSCIENCE, INC.
Reel/Frame 044786/0289 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2017
From: MATRIX GENETICS, LLC
To: LUMEN BIOSCIENCE, INC.
Reel/Frame 043770/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 2, 2012
From: TARGETED GROWTH, INC.
To: MATRIX GENETICS, LLC
Reel/Frame 028141/0654 →
SECURITY AGREEMENT Recorded May 2, 2012
From: MATRIX GENETICS, LLC
To: AVISTA DEVELOPMENT, INC.
Reel/Frame 028146/0365 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2009
From: ROBERTS, JAMES; CROSS, FRED; WARRENER, PAUL; MUNOZ, ERNEST JAVIER; LEE, MARTIN HENRY; ROMARI, KHADIDJA
To: TARGETED GROWTH, INC.
Reel/Frame 023684/0412 →
Continuity (2)
Provisional Application 61107979 · Oct 23, 2008
Related Publication 20100081178A1 · Apr 1, 2010